566 related articles for article (PubMed ID: 22814930)
1. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
2. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
3. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity.
Liu C; Zhu H; Tu Z; Xu YL; Nelson DR
Hepatology; 2003 Jun; 37(6):1335-42. PubMed ID: 12774012
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
7. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
[TBL] [Abstract][Full Text] [Related]
8. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells.
Ebihara T; Shingai M; Matsumoto M; Wakita T; Seya T
Hepatology; 2008 Jul; 48(1):48-58. PubMed ID: 18537195
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture Model.
Ojiro K; Qu X; Cho H; Park JJ; Vuidepot A; Lissin N; Molloy PE; Bennett A; Jakobsen BK; Kaplan DE; Riley JL; Chang KM
J Virol; 2017 May; 91(10):. PubMed ID: 28275182
[TBL] [Abstract][Full Text] [Related]
11. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes.
Stevenson NJ; Bourke NM; Ryan EJ; Binder M; Fanning L; Johnston JA; Hegarty JE; Long A; O'Farrelly C
FEBS Lett; 2013 May; 587(10):1571-8. PubMed ID: 23587486
[TBL] [Abstract][Full Text] [Related]
14. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways.
Hassan M; Selimovic D; Ghozlan H; Abdel-kader O
Hepatology; 2009 May; 49(5):1469-82. PubMed ID: 19235829
[TBL] [Abstract][Full Text] [Related]
16. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
[TBL] [Abstract][Full Text] [Related]
17. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
[TBL] [Abstract][Full Text] [Related]
18. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
[TBL] [Abstract][Full Text] [Related]
19. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
20. Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation.
Ishida H; Kato T; Takehana K; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(1):127-33. PubMed ID: 23806690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]